EH
IBB icon

Equitable Holdings’s iShares Biotechnology ETF IBB Stock Holding History

Equitable Holdings’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.57M Buy
33,007
+9,715
+42% +$1.66M 0.04% 403
2025
Q4 		$3.93M Buy
23,292
+7,805
+50% +$1.27M 0.03% 434
2025
Q3 		$2.24M Sell
15,487
-501
-3% -$68.4K 0.02% 575
2025
Q2 		$2.02M Sell
15,988
-872
-5% -$107K 0.02% 569
2025
Q1 		$2.16M Buy
16,860
+127
+0.8% +$17.2K 0.02% 497
2024
Q4 		$2.21M Buy
16,733
+4,004
+31% +$563K 0.02% 465
2024
Q3 		$1.85M Sell
12,729
-1,018
-7% -$147K 0.02% 512
2024
Q2 		$1.89M Buy
13,747
+3,834
+39% +$512K 0.02% 480
2024
Q1 		$1.36M Sell
9,913
-364
-4% -$49.7K 0.02% 546
2023
Q4 		$1.4M Sell
10,277
-233
-2% -$28.4K 0.02% 504
2023
Q3 		$1.29M Sell
10,510
-89
-0.8% -$11.3K 0.02% 475
2023
Q2 		$1.35M Sell
10,599
-104
-1% -$13.5K 0.02% 443
2023
Q1 		$1.38M Buy
10,703
+378
+4% +$49.5K 0.02% 410
2022
Q4 		$1.36M Buy
10,325
+1,465
+17% +$189K 0.02% 374
2022
Q3 		$1.04M Buy
8,860
+346
+4% +$43K 0.02% 399
2022
Q2 		$1M Sell
8,514
-45
-0.5% -$5.34K 0.02% 408
2022
Q1 		$1.11M Sell
8,559
-4,601
-35% -$599K 0.02% 388
2021
Q4 		$2.01M Buy
13,160
+2,602
+25% +$403K 0.03% 280
2021
Q3 		$1.71M Buy
10,558
+193
+2% +$32.5K 0.03% 288
2021
Q2 		$1.7M Sell
10,365
-738
-7% -$114K 0.03% 277
2021
Q1 		$1.67M Sell
11,103
-2,700
-20% -$429K 0.04% 271
2020
Q4 		$2.09M Sell
13,803
-269
-2% -$38.4K 0.05% 216
2020
Q3 		$1.91M Buy
14,072
+241
+2% +$32.7K 0.05% 217
2020
Q2 		$1.89M Buy
13,831
+1,364
+11% +$174K 0.05% 213
2020
Q1 		$1.34M Sell
12,467
-3,200
-20% -$368K 0.05% 221
2019
Q4 		$1.89M Buy
+15,667
New +$1.75M 0.06% 203

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Equitable Holdings's IBB Position: Q1 2026 in Review

Equitable Holdings increased its iShares Biotechnology ETF (IBB) stake by 42% in Q1 2026, buying an estimated $1.66M and bringing the position to 33,007 shares worth $5.57M. The position accounts for 0.04% of the portfolio, ranked #403.

Equitable Holdings first reported a position in IBB in Q4 2019 and has held it in 26 quarters since. 917 funds tracked by Wall St. Rank hold IBB as of Q1 2026.

  • Equitable Holdings held 33,007 shares of iShares Biotechnology ETF worth $5.57M as of Q1 2026.
  • Equitable Holdings bought 9,715 iShares Biotechnology ETF shares in Q1 2026, an estimated $1.66M.
  • iShares Biotechnology ETF made up 0.04% of Equitable Holdings's portfolio in Q1 2026, its #403 holding.
  • Equitable Holdings first reported a position in iShares Biotechnology ETF in Q4 2019 and has held it in 26 quarters since.
  • 917 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2026.

Based on Equitable Holdings's 13F filing for Q1 2026, filed 15 May 2026.